AIMT

Aimmune Therapeutics, Inc.CIK 1631650 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for AIMT PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for AIMT

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Societe des Produits Nestle S.A.	10% Owner	2	$1.87B	$0	2020-10-13
Oxtoby Andrew	Chief Commercial Officer	14	$44.3K	$0	2020-10-13
Dallas Jayson Donald Alexander	President and CEO	18	$150.5K	$0	2020-10-13
Seltzer Stacey Denenberg	Director	17	$0	$0	2020-10-13
Behar Gregory	Director	15	$0	$0	2020-10-13
HAUMANN BRETT K	Director	5	$0	$0	2020-10-13
Sheehy Douglas T.	See Remarks	72	$0	$2.92M	2020-10-13
Iwicki Mark T	Director	19	$620.0K	$0	2020-10-13
ENRIGHT PATRICK G	Director, 10% Owner	34	$8.01M	$0	2020-10-13
MCDADE MARK	Director	17	$266.6K	$0	2020-10-13
ADELMAN DANIEL C MD	Chief Medical Officer	43	$0	$3.49M	2020-10-13
FALBERG KATHRYN E	Director	20	$1.36M	$0	2020-10-13
BJERKHOLT ERIC	Chief Financial Officer	24	$316.9K	$0	2020-10-13
NESTLE SA	10% Owner	4	$200.00M	$0	2020-04-22
Rozenman Mary M.	See Remarks	61	$0	$6.74M	2019-02-22
NIMCO US, Inc.	10% Owner	2	$128.00M	$0	2018-11-28
Barrowcliffe Susan E.	General Manager, Europe	45	$0	$6.14M	2018-11-19
DILLY STEPHEN GEORGE	See Remarks	62	$0	$21.29M	2018-06-11
Knapp Jeffrey H	Chief Operating Officer	6	$0	$0	2018-03-04
Tammenoms Bakker Juliet	10% Owner	3	$1.39M	$0	2018-02-22
DeSouza Warren L.	Chief Financial Officer	9	$0	$553.2K	2017-04-03
Longitude Venture Partners II, L.P.	10% Owner	2	$0	$0	2016-11-29
Tananbaum James B.	10% Owner	2	$0	$3.66M	2016-05-31
Elfont Robert Myles	Chief Medical Officer	1	$0	$0	2016-02-26
Foresite Capital Fund II, L.P.	10% Owner	6	$10.85M	$0	2015-08-24
Longitude Capital Partners II, LLC	10% Owner	5	$5.00M	$0	2015-08-11

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
FALBERG KATHRYN E	Director	D To issuer deriv	2020-10-13	2020-10-14	15,398	$17.39	$267.8K	0	SEC↗
FALBERG KATHRYN E	Director	D To issuer deriv	2020-10-13	2020-10-14	11,432	$14.60	$166.9K	0	SEC↗
FALBERG KATHRYN E	Director	D To issuer deriv	2020-10-13	2020-10-14	19,755	$19.10	$377.3K	0	SEC↗
FALBERG KATHRYN E	Director	D To issuer deriv	2020-10-13	2020-10-14	17,500	$16.24	$284.2K	0	SEC↗
FALBERG KATHRYN E	Director	D To issuer deriv	2020-10-13	2020-10-14	7,500	$1.71	$12.8K	0	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	D To issuer deriv	2020-10-13	2020-10-14	71,250	$10.78	$768.1K	0	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	D To issuer deriv	2020-10-13	2020-10-14	70,000	$14.87	$1.04M	0	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	D To issuer deriv	2020-10-13	2020-10-14	56,250	$0.43	$24.2K	0	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	D To issuer deriv	2020-10-13	2020-10-14	52,500	$10.69	$561.2K	0	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	D To issuer deriv	2020-10-13	2020-10-14	135,068	$23.05	$3.11M	0	SEC↗
ENRIGHT PATRICK G	Director	D To issuer deriv	2020-10-13	2020-10-14	17,500	$16.24	$284.2K	0	SEC↗
ENRIGHT PATRICK G	Director	D To issuer deriv	2020-10-13	2020-10-14	19,755	$19.10	$377.3K	0	SEC↗
ENRIGHT PATRICK G	Director	D To issuer deriv	2020-10-13	2020-10-14	52,421	$28.21	$1.48M	0	SEC↗
ENRIGHT PATRICK G	Director	D To issuer deriv	2020-10-13	2020-10-14	65,849	$34.36	$2.26M	0	SEC↗
ENRIGHT PATRICK G	Director	D To issuer deriv	2020-10-13	2020-10-14	7,500	$1.71	$12.8K	0	SEC↗
ENRIGHT PATRICK G	Director	D To issuer deriv	2020-10-13	2020-10-14	11,432	$14.60	$166.9K	0	SEC↗
ENRIGHT PATRICK G	Director	D To issuer deriv	2020-10-13	2020-10-14	15,398	$17.39	$267.8K	0	SEC↗
Iwicki Mark T	Director	D To issuer deriv	2020-10-13	2020-10-14	87,368	$28.21	$2.46M	0	SEC↗
Iwicki Mark T	Director	D To issuer deriv	2020-10-13	2020-10-14	52,421	$31.48	$1.65M	0	SEC↗
Iwicki Mark T	Director	D To issuer deriv	2020-10-13	2020-10-14	19,755	$19.10	$377.3K	0	SEC↗
Iwicki Mark T	Director	D To issuer deriv	2020-10-13	2020-10-14	17,500	$16.24	$284.2K	0	SEC↗
Iwicki Mark T	Director	D To issuer deriv	2020-10-13	2020-10-14	7,500	$1.71	$12.8K	0	SEC↗
Iwicki Mark T	Director	D To issuer deriv	2020-10-13	2020-10-14	11,432	$14.60	$166.9K	0	SEC↗
Iwicki Mark T	Director	D To issuer deriv	2020-10-13	2020-10-14	15,398	$17.39	$267.8K	0	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	D To issuer deriv	2020-10-13	2020-10-14	56,250	$10.69	$601.3K	0	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	D To issuer deriv	2020-10-13	2020-10-14	78,750	$10.78	$848.9K	0	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	D To issuer deriv	2020-10-13	2020-10-14	56,250	$0.43	$24.2K	0	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	D To issuer deriv	2020-10-13	2020-10-14	264,800	$15.06	$3.99M	0	SEC↗
Seltzer Stacey Denenberg	Director	D To issuer deriv	2020-10-13	2020-10-14	15,398	$17.39	$267.8K	0	SEC↗
Seltzer Stacey Denenberg	Director	D To issuer deriv	2020-10-13	2020-10-14	11,432	$14.60	$166.9K	0	SEC↗
Seltzer Stacey Denenberg	Director	D To issuer deriv	2020-10-13	2020-10-14	7,500	$1.71	$12.8K	0	SEC↗
Seltzer Stacey Denenberg	Director	D To issuer deriv	2020-10-13	2020-10-14	19,755	$19.10	$377.3K	0	SEC↗
Seltzer Stacey Denenberg	Director	D To issuer deriv	2020-10-13	2020-10-14	17,500	$16.24	$284.2K	0	SEC↗
Seltzer Stacey Denenberg	Director	D To issuer deriv	2020-10-13	2020-10-14	52,421	$28.21	$1.48M	0	SEC↗
HAUMANN BRETT K	Director	D To issuer deriv	2020-10-13	2020-10-14	25,453	$17.39	$442.6K	0	SEC↗
Behar Gregory	Director	D To issuer deriv	2020-10-13	2020-10-14	15,398	$17.39	$267.8K	0	SEC↗
Behar Gregory	Director	D To issuer deriv	2020-10-13	2020-10-14	11,432	$14.60	$166.9K	0	SEC↗
Behar Gregory	Director	D To issuer deriv	2020-10-13	2020-10-14	7,500	$1.71	$12.8K	0	SEC↗
Behar Gregory	Director	D To issuer deriv	2020-10-13	2020-10-14	17,500	$16.24	$284.2K	0	SEC↗
Behar Gregory	Director	D To issuer deriv	2020-10-13	2020-10-14	39,510	$9.60	$379.3K	0	SEC↗
MCDADE MARK	Director	D To issuer deriv	2020-10-13	2020-10-14	19,755	$19.10	$377.3K	0	SEC↗
MCDADE MARK	Director	D To issuer deriv	2020-10-13	2020-10-14	104,842	$31.48	$3.30M	0	SEC↗
MCDADE MARK	Director	D To issuer deriv	2020-10-13	2020-10-14	17,500	$16.24	$284.2K	0	SEC↗
MCDADE MARK	Director	D To issuer deriv	2020-10-13	2020-10-14	7,500	$1.71	$12.8K	0	SEC↗
MCDADE MARK	Director	D To issuer deriv	2020-10-13	2020-10-14	11,432	$14.60	$166.9K	0	SEC↗
MCDADE MARK	Director	D To issuer deriv	2020-10-13	2020-10-14	15,398	$17.39	$267.8K	0	SEC↗
Dallas Jayson Donald Alexander	President and CEO	D To issuer deriv	2020-10-13	2020-10-14	200,000	$10.69	$2.14M	0	SEC↗
Dallas Jayson Donald Alexander	President and CEO	D To issuer deriv	2020-10-13	2020-10-14	210,000	$10.78	$2.26M	0	SEC↗
Dallas Jayson Donald Alexander	President and CEO	D To issuer deriv	2020-10-13	2020-10-14	350,000	$3.82	$1.34M	0	SEC↗
Sheehy Douglas T.	See Remarks	D To issuer deriv	2020-10-13	2020-10-14	75,000	$0.43	$32.3K	0	SEC↗
Sheehy Douglas T.	See Remarks	D To issuer deriv	2020-10-13	2020-10-14	67,500	$14.87	$1.00M	0	SEC↗
Sheehy Douglas T.	See Remarks	D To issuer deriv	2020-10-13	2020-10-14	75,000	$10.78	$808.5K	0	SEC↗
Sheehy Douglas T.	See Remarks	D To issuer deriv	2020-10-13	2020-10-14	67,500	$10.69	$721.6K	0	SEC↗
Sheehy Douglas T.	See Remarks	D To issuer deriv	2020-10-13	2020-10-14	22,361	$21.55	$481.9K	0	SEC↗
Oxtoby Andrew	Chief Commercial Officer	D To issuer deriv	2020-10-13	2020-10-14	150,000	$12.56	$1.88M	0	SEC↗
Oxtoby Andrew	Chief Commercial Officer	D To issuer deriv	2020-10-13	2020-10-14	67,500	$10.69	$721.6K	0	SEC↗
FALBERG KATHRYN E	Director	D To issuer	2020-10-13	2020-10-14	7,840	$34.50	$270.5K	0	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	D To issuer	2020-10-13	2020-10-14	22,343	$34.50	$770.8K	0	SEC↗
ENRIGHT PATRICK G	Director	D To issuer	2020-10-13	2020-10-14	7,840	$34.50	$270.5K	0	SEC↗
Iwicki Mark T	Director	D To issuer	2020-10-13	2020-10-14	7,840	$34.50	$270.5K	0	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	D To issuer	2020-10-13	2020-10-14	23,905	$34.50	$824.7K	0	SEC↗
Seltzer Stacey Denenberg	Director	D To issuer	2020-10-13	2020-10-14	7,840	$34.50	$270.5K	0	SEC↗
HAUMANN BRETT K	Director	D To issuer	2020-10-13	2020-10-14	13,313	$34.50	$459.3K	0	SEC↗
Behar Gregory	Director	J Other	2020-10-13	2020-10-14	10,192	—	$0	0	SEC↗
Behar Gregory	Director	D To issuer	2020-10-13	2020-10-14	7,840	$34.50	$270.5K	0	SEC↗
MCDADE MARK	Director	D To issuer	2020-10-13	2020-10-14	7,840	$34.50	$270.5K	0	SEC↗
Dallas Jayson Donald Alexander	President and CEO	D To issuer	2020-10-13	2020-10-14	89,250	$34.50	$3.08M	0	SEC↗
Sheehy Douglas T.	See Remarks	D To issuer	2020-10-13	2020-10-14	36,875	$34.50	$1.27M	0	SEC↗
Oxtoby Andrew	Chief Commercial Officer	D To issuer	2020-10-13	2020-10-14	20,250	$34.50	$698.6K	0	SEC↗
Societe des Produits Nestle S.	10% Owner	P Buy	2020-10-13	2020-10-15	10,681,704	$34.50	$368.52M	23,408,817	SEC↗
Societe des Produits Nestle S.	10% Owner	P Buy	2020-10-13	2020-10-15	43,435,583	$34.50	$1.50B	43,435,583	SEC↗
FALBERG KATHRYN E	Director	U Tender	2020-10-10	2020-10-14	69,894	$34.50	$2.41M	0	SEC↗
FALBERG KATHRYN E	Director	U Tender	2020-10-10	2020-10-14	65,192	$34.50	$2.25M	0	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	U Tender	2020-10-10	2020-10-14	41,464	$34.50	$1.43M	0	SEC↗
ENRIGHT PATRICK G	Director	U Tender	2020-10-10	2020-10-14	91,697	$34.50	$3.16M	0	SEC↗
ENRIGHT PATRICK G	Director	U Tender	2020-10-10	2020-10-14	70,561	$34.50	$2.43M	0	SEC↗
Iwicki Mark T	Director	U Tender	2020-10-10	2020-10-14	39,567	$34.50	$1.37M	0	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	U Tender	2020-10-10	2020-10-14	27,805	$34.50	$959.3K	0	SEC↗
Seltzer Stacey Denenberg	Director	U Tender	2020-10-10	2020-10-14	10,221	$34.50	$352.6K	0	SEC↗
HAUMANN BRETT K	Director	U Tender	2020-10-10	2020-10-14	6,250	$34.50	$215.6K	0	SEC↗
MCDADE MARK	Director	U Tender	2020-10-10	2020-10-14	26,852	$34.50	$926.4K	0	SEC↗
Dallas Jayson Donald Alexander	President and CEO	U Tender	2020-10-10	2020-10-14	30,422	$34.50	$1.05M	0	SEC↗
Sheehy Douglas T.	See Remarks	U Tender	2020-10-10	2020-10-14	47,450	$34.50	$1.64M	0	SEC↗
Oxtoby Andrew	Chief Commercial Officer	U Tender	2020-10-10	2020-10-14	6,345	$34.50	$218.9K	0	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	M Exercise deriv	2020-10-05	2020-10-05	5,200	—	$0	264,800	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise deriv	2020-10-05	2020-10-05	30,888	—	$0	22,361	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	M Exercise	2020-10-05	2020-10-05	5,200	$19.44	$101.1K	49,841	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise	2020-10-05	2020-10-05	30,888	$12.95	$400.0K	85,426	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	M Exercise deriv	2020-10-02	2020-10-05	34,932	—	$0	135,068	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	M Exercise	2020-10-02	2020-10-05	34,932	$11.45	$400.0K	63,807	SEC↗
ENRIGHT PATRICK G	Director	J Other	2020-09-21	2020-09-23	6,113,134	—	$0	0	SEC↗
ENRIGHT PATRICK G	Director	J Other	2020-09-21	2020-09-23	91,697	—	$0	91,697	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	F Tax w/h	2020-09-15	2020-09-16	840	$34.25	$28.8K	28,875	SEC↗
Dallas Jayson Donald Alexander	President and CEO	F Tax w/h	2020-09-15	2020-09-16	1,642	$34.25	$56.2K	117,034	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	F Tax w/h	2020-09-15	2020-09-16	840	$34.25	$28.8K	44,547	SEC↗
Oxtoby Andrew	Chief Commercial Officer	F Tax w/h	2020-09-15	2020-09-16	840	$34.25	$28.8K	26,595	SEC↗
Sheehy Douglas T.	See Remarks	F Tax w/h	2020-09-15	2020-09-16	840	$34.25	$28.8K	54,538	SEC↗
Dallas Jayson Donald Alexander	President and CEO	F Tax w/h	2020-06-22	2020-06-26	7,907	$18.02	$142.5K	118,676	SEC↗
Seltzer Stacey Denenberg	Director	A Award deriv	2020-05-27	2020-05-29	15,398	—	$0	15,398	SEC↗
MCDADE MARK	Director	A Award deriv	2020-05-27	2020-05-29	15,398	—	$0	15,398	SEC↗
ENRIGHT PATRICK G	Director	A Award deriv	2020-05-27	2020-05-29	15,398	—	$0	15,398	SEC↗
FALBERG KATHRYN E	Director	A Award deriv	2020-05-27	2020-05-29	15,398	—	$0	15,398	SEC↗
HAUMANN BRETT K	Director	A Award deriv	2020-05-27	2020-05-29	25,453	—	$0	25,453	SEC↗
Behar Gregory	Director	A Award deriv	2020-05-27	2020-05-29	15,398	—	$0	15,398	SEC↗
Iwicki Mark T	Director	A Award deriv	2020-05-27	2020-05-29	15,398	—	$0	15,398	SEC↗
Seltzer Stacey Denenberg	Director	A Award	2020-05-27	2020-05-29	7,840	—	$0	18,061	SEC↗
MCDADE MARK	Director	A Award	2020-05-27	2020-05-29	7,840	—	$0	34,692	SEC↗
ENRIGHT PATRICK G	Director	S Sale	2020-05-27	2020-05-29	7,840	—	$0	78,401	SEC↗
FALBERG KATHRYN E	Director	A Award	2020-05-27	2020-05-29	7,840	—	$0	73,032	SEC↗
HAUMANN BRETT K	Director	A Award	2020-05-27	2020-05-29	13,313	—	$0	19,563	SEC↗
Behar Gregory	Director	A Award	2020-05-27	2020-05-29	7,840	—	$0	18,032	SEC↗
Iwicki Mark T	Director	A Award	2020-05-27	2020-05-29	7,840	—	$0	47,407	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	A Award	2020-05-10	2020-05-12	2,420	—	$0	29,715	SEC↗
Oxtoby Andrew	Chief Commercial Officer	A Award	2020-05-10	2020-05-12	2,420	—	$0	27,435	SEC↗
Sheehy Douglas T.	See Remarks	A Award	2020-05-10	2020-05-12	2,420	—	$0	55,378	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	A Award	2020-05-10	2020-05-12	2,420	—	$0	45,387	SEC↗
Dallas Jayson Donald Alexander	President and CEO	A Award	2020-05-10	2020-05-12	3,300	—	$0	126,583	SEC↗
NESTLE SA	10% Owner	J Other	2020-04-22	2020-04-24	525,634	$161.10	$84.68M	525,634	SEC↗
NESTLE SA	10% Owner	J Other	2020-04-22	2020-04-24	12,727,113	$16.11	$205.03M	12,727,113	SEC↗
ENRIGHT PATRICK G	Director	P Buy	2020-03-18	2020-03-19	16,213	$11.06	$179.3K	70,561	SEC↗
ENRIGHT PATRICK G	Director	P Buy	2020-03-17	2020-03-19	100,000	$11.40	$1.14M	6,113,134	SEC↗
ENRIGHT PATRICK G	Director	P Buy	2020-03-17	2020-03-19	8,787	$11.50	$101.1K	54,348	SEC↗
Oxtoby Andrew	Chief Commercial Officer	P Buy	2020-03-13	2020-03-17	3,000	$14.76	$44.3K	25,015	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	P Buy	2020-03-12	2020-03-12	1,000	$15.10	$15.1K	42,967	SEC↗
Dallas Jayson Donald Alexander	President and CEO	P Buy	2020-03-10	2020-03-10	2,665	$18.74	$49.9K	123,283	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	P Buy	2020-03-09	2020-03-10	1,000	$18.97	$19.0K	41,967	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	F Tax w/h	2020-03-02	2020-03-04	1,872	$23.81	$44.6K	27,295	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	F Tax w/h	2020-03-02	2020-03-04	1,982	$23.81	$47.2K	40,967	SEC↗
Sheehy Douglas T.	See Remarks	F Tax w/h	2020-03-02	2020-03-04	3,960	$23.81	$94.3K	52,958	SEC↗
Dallas Jayson Donald Alexander	President and CEO	F Tax w/h	2020-03-02	2020-03-04	3,081	$23.81	$73.4K	120,618	SEC↗
Sheehy Douglas T.	See Remarks	A Award deriv	2020-02-28	2020-03-03	67,500	—	$0	67,500	SEC↗
Oxtoby Andrew	Chief Commercial Officer	A Award deriv	2020-02-28	2020-03-03	67,500	—	$0	67,500	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	A Award deriv	2020-02-28	2020-03-03	52,500	—	$0	52,500	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	A Award deriv	2020-02-28	2020-03-03	56,250	—	$0	56,250	SEC↗
Dallas Jayson Donald Alexander	President and CEO	A Award deriv	2020-02-28	2020-03-03	200,000	—	$0	200,000	SEC↗
Oxtoby Andrew	Chief Commercial Officer	A Award deriv	2020-02-28	2020-03-04	67,500	—	$0	67,500	SEC↗
Sheehy Douglas T.	See Remarks	A Award	2020-02-28	2020-03-03	11,250	—	$0	56,918	SEC↗
Oxtoby Andrew	Chief Commercial Officer	A Award	2020-02-28	2020-03-03	11,250	—	$0	23,250	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	A Award	2020-02-28	2020-03-03	8,750	—	$0	29,167	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	A Award	2020-02-28	2020-03-03	9,375	—	$0	42,949	SEC↗
Dallas Jayson Donald Alexander	President and CEO	A Award	2020-02-28	2020-03-03	33,000	—	$0	123,699	SEC↗
Oxtoby Andrew	Chief Commercial Officer	A Award	2020-02-28	2020-03-04	11,250	—	$0	22,015	SEC↗
NESTLE SA	10% Owner	P Buy	2020-02-07	2020-04-24	525,634	$319.68	$168.03M	525,634	SEC↗
NESTLE SA	10% Owner	P Buy	2020-02-07	2020-04-24	1,000,000	$31.97	$31.97M	12,727,113	SEC↗
Oxtoby Andrew	Chief Commercial Officer	F Tax w/h	2020-01-22	2020-03-04	1,235	$33.23	$41.0K	10,765	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise deriv	2020-01-16	2020-01-21	400	—	$0	53,249	SEC↗
Sheehy Douglas T.	See Remarks	S Sale	2020-01-16	2020-01-21	400	$37.00	$14.8K	45,668	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise	2020-01-16	2020-01-21	400	$12.95	$5.2K	46,068	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	M Exercise deriv	2020-01-02	2020-01-03	20,000	—	$0	70,000	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	S Sale	2020-01-02	2020-01-03	20,000	$35.00	$700.0K	21,250	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	M Exercise	2020-01-02	2020-01-03	20,000	$19.63	$392.6K	41,250	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise deriv	2019-12-26	2019-12-30	10,000	—	$0	53,649	SEC↗
Sheehy Douglas T.	See Remarks	S Sale	2019-12-26	2019-12-30	10,000	$33.03	$330.3K	45,668	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise	2019-12-26	2019-12-30	10,000	$12.95	$129.5K	55,668	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	M Exercise deriv	2019-12-09	2019-12-11	20,000	—	$0	170,000	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	M Exercise	2019-12-09	2019-12-11	20,000	$11.45	$229.0K	41,250	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	S Sale	2019-12-09	2019-12-11	20,000	$30.04	$600.8K	21,250	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	P Buy	2019-09-18	2019-09-20	1,550	$22.57	$35.0K	33,574	SEC↗
ENRIGHT PATRICK G	Director	A Award	2019-09-17	2019-09-19	12,500	$22.34	$279.3K	45,561	SEC↗
Iwicki Mark T	Director	A Award deriv	2019-05-23	2019-05-28	11,432	—	$0	11,432	SEC↗
ENRIGHT PATRICK G	Director	A Award deriv	2019-05-23	2019-05-28	11,432	—	$0	11,432	SEC↗
Seltzer Stacey Denenberg	Director	A Award deriv	2019-05-23	2019-05-28	11,432	—	$0	11,432	SEC↗
FALBERG KATHRYN E	Director	A Award deriv	2019-05-23	2019-05-28	11,432	—	$0	11,432	SEC↗
MCDADE MARK	Director	A Award deriv	2019-05-23	2019-05-28	11,432	—	$0	11,432	SEC↗
Behar Gregory	Director	A Award deriv	2019-05-23	2019-05-28	11,432	—	$0	11,432	SEC↗
Iwicki Mark T	Director	A Award	2019-05-23	2019-05-28	6,442	—	$0	39,567	SEC↗
ENRIGHT PATRICK G	Director	A Award	2019-05-23	2019-05-28	6,442	—	$0	33,061	SEC↗
Seltzer Stacey Denenberg	Director	A Award	2019-05-23	2019-05-28	6,442	—	$0	10,221	SEC↗
FALBERG KATHRYN E	Director	A Award	2019-05-23	2019-05-28	6,442	—	$0	65,192	SEC↗
MCDADE MARK	Director	A Award	2019-05-23	2019-05-28	6,442	—	$0	26,852	SEC↗
Behar Gregory	Director	A Award	2019-05-23	2019-05-28	6,442	—	$0	10,192	SEC↗
Dallas Jayson Donald Alexander	President and CEO	A Award deriv	2019-02-22	2019-02-26	210,000	—	$0	210,000	SEC↗
Rozenman Mary M.	See Remarks	A Award deriv	2019-02-22	2019-02-26	45,000	—	$0	45,000	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	A Award deriv	2019-02-22	2019-02-26	78,750	—	$0	78,750	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	A Award deriv	2019-02-22	2019-02-26	71,250	—	$0	71,250	SEC↗
Sheehy Douglas T.	See Remarks	A Award deriv	2019-02-22	2019-02-26	75,000	—	$0	75,000	SEC↗
Dallas Jayson Donald Alexander	President and CEO	A Award	2019-02-22	2019-02-26	35,000	—	$0	98,650	SEC↗
Rozenman Mary M.	See Remarks	A Award	2019-02-22	2019-02-26	7,500	—	$0	14,504	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	A Award	2019-02-22	2019-02-26	13,125	—	$0	32,857	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	A Award	2019-02-22	2019-02-26	11,875	—	$0	21,250	SEC↗
Sheehy Douglas T.	See Remarks	A Award	2019-02-22	2019-02-26	12,500	—	$0	45,668	SEC↗
Oxtoby Andrew	Chief Commercial Officer	A Award deriv	2019-01-22	2019-01-24	150,000	—	$0	150,000	SEC↗
Oxtoby Andrew	Chief Commercial Officer	A Award	2019-01-22	2019-01-24	12,000	—	$0	12,000	SEC↗
NIMCO US, Inc.	10% Owner	P Buy	2018-11-28	2020-04-24	3,237,529	$30.27	$98.00M	11,727,113	SEC↗
Barrowcliffe Susan E.	General Manager, Europe	M Exercise deriv	2018-11-19	2018-11-21	40,000	—	$0	53,400	SEC↗
Dallas Jayson Donald Alexander	President and CEO	P Buy	2018-11-19	2018-11-19	3,600	$27.56	$99.2K	63,600	SEC↗
Dallas Jayson Donald Alexander	President and CEO	P Buy	2018-11-19	2018-11-19	50	$27.56	$1.4K	63,650	SEC↗
Barrowcliffe Susan E.	General Manager, Europe	S Sale	2018-11-19	2018-11-21	40,000	$30.04	$1.20M	9,375	SEC↗
Barrowcliffe Susan E.	General Manager, Europe	M Exercise	2018-11-19	2018-11-21	40,000	$3.02	$120.8K	49,375	SEC↗
FALBERG KATHRYN E	Director	G Gift	2018-11-01	2019-05-28	69,894	—	$0	69,894	SEC↗
FALBERG KATHRYN E	Director	G Gift	2018-11-01	2019-05-28	69,894	—	$0	58,750	SEC↗
Dallas Jayson Donald Alexander	President and CEO	A Award deriv	2018-06-19	2018-06-19	350,000	—	$0	350,000	SEC↗
Dallas Jayson Donald Alexander	President and CEO	A Award	2018-06-19	2018-06-19	60,000	—	$0	60,000	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	P Buy	2018-06-13	2018-06-14	1,600	$30.41	$48.7K	19,485	SEC↗
DILLY STEPHEN GEORGE	President and CEO	M Exercise deriv	2018-06-11	2018-06-13	29,457	—	$0	295,942	SEC↗
DILLY STEPHEN GEORGE	President and CEO	M Exercise	2018-06-11	2018-06-13	29,457	$3.02	$89.0K	344,765	SEC↗
DILLY STEPHEN GEORGE	President and CEO	S Sale	2018-06-11	2018-06-13	29,457	$30.83	$908.2K	315,308	SEC↗
DILLY STEPHEN GEORGE	President and CEO	M Exercise deriv	2018-06-08	2018-06-08	42,106	—	$0	325,399	SEC↗
DILLY STEPHEN GEORGE	President and CEO	M Exercise	2018-06-08	2018-06-08	42,106	$3.02	$127.2K	357,414	SEC↗
DILLY STEPHEN GEORGE	President and CEO	S Sale	2018-06-08	2018-06-08	42,106	$30.70	$1.29M	315,308	SEC↗
DILLY STEPHEN GEORGE	President and CEO	M Exercise deriv	2018-06-07	2018-06-08	32,598	—	$0	367,505	SEC↗
DILLY STEPHEN GEORGE	President and CEO	S Sale	2018-06-07	2018-06-08	32,098	$30.95	$993.4K	315,808	SEC↗
DILLY STEPHEN GEORGE	President and CEO	M Exercise	2018-06-07	2018-06-08	32,598	$3.02	$98.4K	347,906	SEC↗
DILLY STEPHEN GEORGE	President and CEO	S Sale	2018-06-07	2018-06-08	500	$31.58	$15.8K	315,308	SEC↗
DILLY STEPHEN GEORGE	President and CEO	M Exercise deriv	2018-06-06	2018-06-08	30,465	—	$0	400,103	SEC↗
DILLY STEPHEN GEORGE	President and CEO	M Exercise	2018-06-06	2018-06-08	30,465	$3.02	$92.0K	345,773	SEC↗
DILLY STEPHEN GEORGE	President and CEO	S Sale	2018-06-06	2018-06-08	30,465	$31.20	$950.5K	315,308	SEC↗
DILLY STEPHEN GEORGE	See Remarks	M Exercise deriv	2018-06-05	2018-06-05	38,825	—	$0	430,568	SEC↗
DILLY STEPHEN GEORGE	See Remarks	M Exercise	2018-06-05	2018-06-05	38,825	$3.02	$117.3K	354,133	SEC↗
DILLY STEPHEN GEORGE	See Remarks	S Sale	2018-06-05	2018-06-05	38,825	$31.83	$1.24M	315,308	SEC↗
DILLY STEPHEN GEORGE	See Remarks	M Exercise deriv	2018-06-04	2018-06-05	65,352	—	$0	469,393	SEC↗
DILLY STEPHEN GEORGE	See Remarks	S Sale	2018-06-04	2018-06-05	2,612	$32.74	$85.5K	315,308	SEC↗
DILLY STEPHEN GEORGE	See Remarks	S Sale	2018-06-04	2018-06-05	62,740	$31.84	$2.00M	317,920	SEC↗
DILLY STEPHEN GEORGE	See Remarks	M Exercise	2018-06-04	2018-06-05	65,352	$3.02	$197.4K	380,660	SEC↗
DILLY STEPHEN GEORGE	See Remarks	M Exercise deriv	2018-06-01	2018-06-05	61,197	—	$0	534,745	SEC↗
DILLY STEPHEN GEORGE	See Remarks	S Sale	2018-06-01	2018-06-05	58,699	$32.59	$1.91M	317,806	SEC↗
DILLY STEPHEN GEORGE	See Remarks	S Sale	2018-06-01	2018-06-05	2,498	$33.19	$82.9K	315,308	SEC↗
DILLY STEPHEN GEORGE	See Remarks	M Exercise	2018-06-01	2018-06-05	61,197	$3.02	$184.8K	376,505	SEC↗
MCDADE MARK	Director	A Award deriv	2018-05-23	2018-05-24	7,500	—	$0	7,500	SEC↗
FALBERG KATHRYN E	Director	A Award deriv	2018-05-23	2018-05-24	7,500	—	$0	7,500	SEC↗
Iwicki Mark T	Director	A Award deriv	2018-05-23	2018-05-24	7,500	—	$0	7,500	SEC↗
Behar Gregory	Director	A Award deriv	2018-05-23	2018-05-24	7,500	—	$0	7,500	SEC↗
Seltzer Stacey Denenberg	Director	A Award deriv	2018-05-23	2018-05-24	7,500	—	$0	7,500	SEC↗
ENRIGHT PATRICK G	Director, 10% Owner	A Award deriv	2018-05-23	2018-05-24	7,500	—	$0	7,500	SEC↗
MCDADE MARK	Director	A Award	2018-05-23	2018-05-24	3,750	—	$0	20,410	SEC↗
FALBERG KATHRYN E	Director	A Award	2018-05-23	2018-05-24	3,750	—	$0	128,644	SEC↗
Iwicki Mark T	Director	A Award	2018-05-23	2018-05-24	3,750	—	$0	33,125	SEC↗
Behar Gregory	Director	A Award	2018-05-23	2018-05-24	3,750	—	$0	3,750	SEC↗
Seltzer Stacey Denenberg	Director	A Award	2018-05-23	2018-05-24	3,750	—	$0	3,779	SEC↗
ENRIGHT PATRICK G	Director, 10% Owner	A Award	2018-05-23	2018-05-24	3,750	—	$0	26,619	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise deriv	2018-05-22	2018-05-24	1,648	—	$0	65,297	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise deriv	2018-05-22	2018-05-24	1,648	—	$0	63,649	SEC↗
Sheehy Douglas T.	See Remarks	S Sale	2018-05-22	2018-05-24	1,648	$33.00	$54.4K	33,079	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise	2018-05-22	2018-05-24	1,648	$12.95	$21.3K	34,727	SEC↗
Sheehy Douglas T.	See Remarks	S Sale	2018-05-22	2018-05-24	1,648	$33.00	$54.4K	33,079	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise	2018-05-22	2018-05-24	1,648	$12.95	$21.3K	34,727	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise deriv	2018-03-05	2018-03-06	1,648	—	$0	66,945	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise deriv	2018-03-05	2018-03-06	1,875	—	$0	67,500	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise	2018-03-05	2018-03-06	1,648	$12.95	$21.3K	34,148	SEC↗
Sheehy Douglas T.	See Remarks	S Sale	2018-03-05	2018-03-06	1,875	$37.00	$69.4K	32,500	SEC↗
Sheehy Douglas T.	See Remarks	S Sale	2018-03-05	2018-03-06	700	$36.60	$25.6K	32,500	SEC↗
Sheehy Douglas T.	See Remarks	S Sale	2018-03-05	2018-03-06	948	$35.52	$33.7K	33,200	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise	2018-03-05	2018-03-06	1,875	$19.63	$36.8K	34,375	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	A Award deriv	2018-03-04	2018-03-06	56,250	—	$0	56,250	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	A Award deriv	2018-03-04	2018-03-06	56,250	—	$0	56,250	SEC↗
Sheehy Douglas T.	See Remarks	A Award deriv	2018-03-04	2018-03-06	75,000	—	$0	75,000	SEC↗
Rozenman Mary M.	See Remarks	A Award deriv	2018-03-04	2018-03-06	41,250	—	$0	41,250	SEC↗
Knapp Jeffrey H	Chief Operating Officer	A Award deriv	2018-03-04	2018-03-06	56,250	—	$0	56,250	SEC↗
Barrowcliffe Susan E.	General Manager, Europe	A Award deriv	2018-03-04	2018-03-06	56,250	—	$0	56,250	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	A Award	2018-03-04	2018-03-06	9,375	—	$0	17,500	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	A Award	2018-03-04	2018-03-06	9,375	—	$0	9,375	SEC↗
Sheehy Douglas T.	See Remarks	A Award	2018-03-04	2018-03-06	32,500	—	$0	32,500	SEC↗
Rozenman Mary M.	See Remarks	A Award	2018-03-04	2018-03-06	6,875	—	$0	7,004	SEC↗
Knapp Jeffrey H	Chief Operating Officer	A Award	2018-03-04	2018-03-06	9,375	—	$0	12,151	SEC↗
Barrowcliffe Susan E.	General Manager, Europe	A Award	2018-03-04	2018-03-06	9,375	—	$0	9,375	SEC↗
Rozenman Mary M.	See Remarks	M Exercise deriv	2018-03-01	2018-03-05	1,807	—	$0	105,436	SEC↗
Rozenman Mary M.	See Remarks	M Exercise	2018-03-01	2018-03-05	1,807	$3.02	$5.5K	1,936	SEC↗
Rozenman Mary M.	See Remarks	S Sale	2018-03-01	2018-03-05	1,807	$33.10	$59.8K	129	SEC↗
NIMCO US, Inc.	10% Owner	P Buy	2018-02-26	2020-04-24	937,500	$32.00	$30.00M	8,489,584	SEC↗
BJERKHOLT ERIC	Chief Financial Officer	P Buy	2018-02-26	2018-02-26	3,125	$32.00	$100.0K	8,125	SEC↗
FALBERG KATHRYN E	Director	P Buy	2018-02-26	2018-02-26	30,000	$32.00	$960.0K	124,894	SEC↗
Iwicki Mark T	Director	P Buy	2018-02-26	2018-02-26	9,375	$32.00	$300.0K	29,375	SEC↗
ENRIGHT PATRICK G	Director, 10% Owner	P Buy	2018-02-22	2018-02-26	15,593	$32.00	$499.0K	22,869	SEC↗
Tammenoms Bakker Juliet	10% Owner	P Buy	2018-02-22	2018-02-26	9,375	$32.00	$300.0K	16,651	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise deriv	2018-02-05	2018-02-07	1,648	—	$0	68,593	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise	2018-02-05	2018-02-07	1,648	$12.95	$21.3K	1,648	SEC↗
Sheehy Douglas T.	See Remarks	S Sale	2018-02-05	2018-02-07	1,648	$35.87	$59.1K	0	SEC↗
Rozenman Mary M.	See Remarks	M Exercise deriv	2018-02-01	2018-02-05	6,592	—	$0	107,243	SEC↗
Rozenman Mary M.	See Remarks	M Exercise	2018-02-01	2018-02-05	6,592	$3.02	$19.9K	6,721	SEC↗
Rozenman Mary M.	See Remarks	S Sale	2018-02-01	2018-02-05	2,300	$34.95	$80.4K	4,421	SEC↗
Rozenman Mary M.	See Remarks	S Sale	2018-02-01	2018-02-05	4,292	$35.58	$152.7K	129	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise deriv	2018-01-24	2018-01-26	1,875	—	$0	69,375	SEC↗
Sheehy Douglas T.	See Remarks	S Sale	2018-01-24	2018-01-26	1,875	$38.15	$71.5K	0	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise	2018-01-24	2018-01-26	1,875	$19.63	$36.8K	1,875	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	M Exercise deriv	2018-01-16	2018-01-16	9,933	—	$0	190,000	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	S Sale	2018-01-16	2018-01-16	9,933	$40.00	$397.3K	0	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	M Exercise	2018-01-16	2018-01-16	9,933	$11.45	$113.7K	9,933	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	M Exercise deriv	2018-01-12	2018-01-16	26,784	—	$0	199,933	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	S Sale	2018-01-12	2018-01-16	26,784	$40.00	$1.07M	0	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	M Exercise	2018-01-12	2018-01-16	26,784	$11.45	$306.7K	26,784	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise deriv	2018-01-04	2018-01-08	1,648	—	$0	70,241	SEC↗
Sheehy Douglas T.	See Remarks	S Sale	2018-01-04	2018-01-08	1,648	$37.33	$61.5K	0	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise	2018-01-04	2018-01-08	1,648	$12.95	$21.3K	1,648	SEC↗
Barrowcliffe Susan E.	General Manager, Europe	M Exercise deriv	2018-01-02	2018-01-04	75,000	—	$0	93,400	SEC↗
Rozenman Mary M.	See Remarks	M Exercise deriv	2018-01-02	2018-01-04	6,591	—	$0	113,835	SEC↗
Barrowcliffe Susan E.	General Manager, Europe	S Sale	2018-01-02	2018-01-04	300	$37.86	$11.4K	25,000	SEC↗
Barrowcliffe Susan E.	General Manager, Europe	S Sale	2018-01-02	2018-01-04	24,400	$37.12	$905.7K	600	SEC↗
Barrowcliffe Susan E.	General Manager, Europe	M Exercise	2018-01-02	2018-01-04	75,000	$3.02	$226.5K	75,000	SEC↗
Barrowcliffe Susan E.	General Manager, Europe	S Sale	2018-01-02	2018-01-04	600	$37.75	$22.6K	0	SEC↗
Barrowcliffe Susan E.	General Manager, Europe	S Sale	2018-01-02	2018-01-04	599	$37.78	$22.6K	50,000	SEC↗
Barrowcliffe Susan E.	General Manager, Europe	S Sale	2018-01-02	2018-01-04	24,401	$37.12	$905.8K	50,599	SEC↗
Barrowcliffe Susan E.	General Manager, Europe	S Sale	2018-01-02	2018-01-04	24,700	$37.13	$917.1K	25,300	SEC↗
Rozenman Mary M.	See Remarks	S Sale	2018-01-02	2018-01-04	4,990	$37.12	$185.2K	1,730	SEC↗
Rozenman Mary M.	See Remarks	S Sale	2018-01-02	2018-01-04	1,601	$37.08	$59.4K	129	SEC↗
Rozenman Mary M.	See Remarks	M Exercise	2018-01-02	2018-01-04	6,591	$3.02	$19.9K	6,720	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	M Exercise deriv	2017-12-27	2017-12-29	3,283	—	$0	226,717	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	S Sale	2017-12-27	2017-12-29	3,283	$40.00	$131.3K	0	SEC↗
ADELMAN DANIEL C MD	Chief Medical Officer	M Exercise	2017-12-27	2017-12-29	3,283	$11.45	$37.6K	3,283	SEC↗
Sheehy Douglas T.	See Remarks	M Exercise deriv	2017-12-26	2017-12-28	1,875	—	$0	71,250	SEC↗
Rozenman Mary M.	See Remarks	M Exercise deriv	2017-12-26	2017-12-28	75,010	—	$0	120,426	SEC↗